| Literature DB >> 26673981 |
Youngmin Youn1, Jisoo Kim, Young Mi Hong, Sejung Sohn.
Abstract
Forty-three patients with Kawasaki disease who were resistant to initial intravenous immunoglobulin (IVIG) were randomized to receive either a second dose of IVIG (n = 32) or an infliximab (n = 11). With IVIG retreatment 21 patients (65.6%) responded, and with infliximab 10 patients (90.9%) responded. The infliximab group had shorter duration of fever and fewer days of hospitalization. Coronary artery outcomes and adverse events were similar.Entities:
Mesh：
Substances：
Year: 2016 PMID： 26673981 DOI： 10.1097/INF.0000000000001039
Source DB: PubMed Journal: Pediatr Infect Dis J ISSN： 0891-3668 Impact factor: 2.129